Publications
Detailed Information
FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Dong-Sub | - |
dc.contributor.author | Li, Jin Ji | - |
dc.contributor.author | Kwak, Seung-Jae | - |
dc.contributor.author | Lee, Sun Ha | - |
dc.contributor.author | Park, Jehyun | - |
dc.contributor.author | Song, Young Soo | - |
dc.contributor.author | Yoo, Tae-Hyun | - |
dc.contributor.author | Han, Seung Hyeok | - |
dc.contributor.author | Lee, Jung Eun | - |
dc.contributor.author | Kim, Dong Ki | - |
dc.contributor.author | Moon, Sung Jin | - |
dc.contributor.author | Kim, Yu Seun | - |
dc.contributor.author | Han, Dae Suk | - |
dc.contributor.author | Kang, Shin-Wook | - |
dc.date.accessioned | 2010-07-05T03:26:54Z | - |
dc.date.available | 2010-07-05T03:26:54Z | - |
dc.date.issued | 2008-06-06 | - |
dc.identifier.citation | Am J Physiol Renal Physiol. 295(2):F595-F604 | en |
dc.identifier.issn | 0363-6127 (Print) | - |
dc.identifier.issn | http://dx.doi.org/10.1152/ajprenal.00624.2007 | - |
dc.identifier.issn | http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18524857 | - |
dc.identifier.issn | http://ajprenal.physiology.org/cgi/reprint/295/2/F595.pdf | - |
dc.identifier.uri | https://hdl.handle.net/10371/68248 | - |
dc.description.abstract | Previous in vitro studies suggest that the p38 MAPK pathway may be involved in the pathogenesis of diabetic nephropathy, but the consequences of the inhibition of the p38 MAPK pathway have not been well elucidated in diabetic (DM) glomeruli. This study was undertaken to investigate the effect of p38 MAPK inhibitor, FR167653, on fibronectin expression and apoptosis in DM glomeruli and in high-glucose-stimulated mesangial cells (MC). In vivo, 32 Sprague-Dawley rats were injected with diluent (control, N = 16) or streptozotocin intraperitoneally (DM, N = 16). Eight rats from each group were treated with FR167653 for 3 mo. In vitro, rat MC were exposed to medium containing 5.6 mM glucose or 30 mM glucose [high glucose (HG)] with or without 10(-6) M FR167653 for 24 h. Fibronectin mRNA and protein expression were determined by real-time PCR and Western blot, respectively. Western blot for apoptosis-related molecules, terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling assay, and Hoechst 33342 staining were performed to determine apoptosis. FR167653 ameliorated the increases in fibronectin-to-GAPDH mRNA ratio and protein expression in DM glomeruli by 89 and 79% and in HG-stimulated MC by 70 and 91%, respectively (P < 0.05). Under diabetic conditions, Bcl-2 protein expression was decreased, whereas cleaved caspase-3 protein expression was increased (P < 0.05), and these changes were inhibited by FR167653 treatment. Apoptotic cells were also significantly increased in DM glomeruli and in HG-stimulated MC (P < 0.05), and FR167653 ameliorated these increases in apoptotic cells, both in vivo and in vitro. In conclusion, these findings suggest that the inhibition of the p38 MAPK pathway has a beneficial effect on the development of diabetic nephropathy by inhibiting the increase in fibronectin expression and apoptosis. | en |
dc.language.iso | en | en |
dc.publisher | American Physiological Society | en |
dc.subject | Animals | en |
dc.subject | Apoptosis/*drug effects | en |
dc.subject | Caspase 3/metabolism | en |
dc.subject | Cells, Cultured | en |
dc.subject | Cyclic AMP Response Element-Binding Protein/metabolism | en |
dc.subject | Diabetes Mellitus, Experimental/metabolism/*pathology | en |
dc.subject | Dose-Response Relationship, Drug | en |
dc.subject | Enzyme Inhibitors/pharmacology | en |
dc.subject | Fibronectins/*metabolism | en |
dc.subject | Glucose/*pharmacology | en |
dc.subject | Hyperglycemia/metabolism/pathology | en |
dc.subject | Kidney Glomerulus/drug effects/metabolism/*pathology | en |
dc.subject | Male | en |
dc.subject | Mesangial Cells/drug effects/metabolism/*pathology | en |
dc.subject | Proto-Oncogene Proteins c-bcl-2/metabolism | en |
dc.subject | Pyrazoles/*pharmacology | en |
dc.subject | Pyridines/*pharmacology | en |
dc.subject | RNA, Messenger/metabolism | en |
dc.subject | Rats | en |
dc.subject | Rats, Sprague-Dawley | en |
dc.subject | Signal Transduction/drug effects | en |
dc.subject | Streptozocin | en |
dc.subject | bcl-2-Associated X Protein/metabolism | en |
dc.subject | p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors | en |
dc.title | FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells | en |
dc.type | Article | en |
dc.contributor.AlternativeAuthor | 정동섭 | - |
dc.contributor.AlternativeAuthor | 곽승재 | - |
dc.contributor.AlternativeAuthor | 이선하 | - |
dc.contributor.AlternativeAuthor | 박제현 | - |
dc.contributor.AlternativeAuthor | 송영수 | - |
dc.contributor.AlternativeAuthor | 유태현 | - |
dc.contributor.AlternativeAuthor | 한승혁 | - |
dc.contributor.AlternativeAuthor | 이정은 | - |
dc.contributor.AlternativeAuthor | 김동기 | - |
dc.contributor.AlternativeAuthor | 문성진 | - |
dc.contributor.AlternativeAuthor | 김유선 | - |
dc.contributor.AlternativeAuthor | 한대석 | - |
dc.contributor.AlternativeAuthor | 강신욱 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.